Millipore Sigma Vibrant Logo

07-1341 Anti-PHLPP1 Antibody

View Products on Sigmaaldrich.com
07-1341
100 µg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Fulfillment and Delivery Delayed
Fulfillment and Delivery Delayed
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, M, RWB, ICCRbAffinity PurifiedPolyclonal Antibody
      Description
      Catalogue Number07-1341
      DescriptionAnti-PHLPP1 Antibody
      Alternate Names
      • PH domain and leucine rich repeat protein phosphatase
      • PH domain leucine-rich repeat protein phosphatase
      • Pleckstrin homology domain-containing family E protein 1
      • SCN circadian oscillatory protein
      • Suprachiasmatic nucleus circadian oscillatory protein
      Background InformationPHLPP1 is the protein phosphatase responsible for dephosphorylation of the Akt (Ser473) site. Akt (Ser473) is the TORC2 (mTOR) phosphorylation activation site.
      References
      Product Information
      FormatAffinity Purified
      Control
      • Human brain tissue lysate
      PresentationPurified rabbit serum in buffer containing 0.1 M Tris-glycine, pH 7.4, 150 mM NaCl and 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-PHLPP1 Antibody detects level of PHLPP1 & has been published & validated for use in WB & IC.
      Key Applications
      • Western Blotting
      • Immunocytochemistry
      Biological Information
      ImmunogenKLH-conjugated linear peptide corresponding to the C-terminus of PHLPP1.
      EpitopeC-terminus
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostRabbit
      SpecificityThis antibody recognizes the C-terminal region of PHLPP1.
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Species Reactivity NoteProven to react with Human, Mouse and Rat.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • EC 3.1.3.16
      • KIAA0606
      • MGC161555
      • PHLPP1
      • PLEKHE1
      • SCOP
      • hSCOP
      Purification MethodAffinity Purfied
      UniProt Number
      UniProt SummaryFUNCTION: Protein phosphatase that specifically mediates dephosphorylation of 'Ser-473' of AKT1, a protein that regulates the balance between cell survival and apoptosis through a cascade that primarily alters the function of transcription factors that regulate pro- and antiapoptotic genes. Dephosphorylation of 'Ser-473' of AKT1 triggers apoptosis and suppression of tumor growth. Controls the phosphorylation of AKT2 and AKT3 more efficiently than that of AKT1. May act as a negative regulator of K-Ras signaling in the membrane rafts.

      CATALYTIC ACTIVITY: A phosphoprotein + H2O = a protein + phosphate.

      COFACTOR: Binds 2 manganese ions per subunit By similarity.

      ENZYME REGULATION: Insensitive to okadaic acid.

      SUBUNIT STRUCTUE: Interacts with nucleotide free form K-Ras (KRAS) via its LRR repeats By similarity.

      SUBCELLULAR LOCATION: Cytoplasm. Membrane; Peripheral membrane protein. Nucleus.

      TISSUE SPECIFICITY: Ubiquitous.

      INVOLVEMENT IN DISEASE: Defects in PHLPP may be a cause of colon cancer. It is hifhly down-regulated in several colon cancer and glioblastoma cell lines with elevates AKT1 phosphorylation. Its reintroduction in such cell lines causes a strong suppression of tumor growth.

      SEQUENCE SIMILARITIES: Contains 19 LRR (leucine-rich) repeats.

      Contains 1 PH domain.

      Contains 1 PP2C-like domain.

      SEQUENCE CAUTION: The sequence AAH82244.1 differs from that shown. Reason: Miscellaneous discrepancy. Contaminating sequence. Potential poly-A sequence.

      Molecular Weight134 kDa. Observed at 110 kDa.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blot in Human brain tissue lysate.
      Western Blot Analysis: A 1:1,000 dilution of this antibody detected PHLPP1 in Human brain tissue lysate.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain refrigerated at 2-8°C for 1 year from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      07-1341 04053252674624

      Documentation

      Anti-PHLPP1 Antibody SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-PHLPP1 Antibody Certificates of Analysis

      TitleLot Number
      Anti-PHLPP1 - 2128253 2128253
      Anti-PHLPP1 - 2006968 2006968
      Anti-PHLPP1 - 2199635 2199635
      Anti-PHLPP1 - 2272150 2272150
      Anti-PHLPP1 - 2287197 2287197
      Anti-PHLPP1 - 2361819 2361819
      Anti-PHLPP1 - 2986173 2986173
      Anti-PHLPP1 - 3224578 3224578
      Anti-PHLPP1 - 3715122 3715122
      Anti-PHLPP1 - 3745510 3745510

      References

      Reference overviewPub Med ID
      A molecular brake controls the magnitude of long-term potentiation.
      Wang, Y; Zhu, G; Briz, V; Hsu, YT; Bi, X; Baudry, M
      Nature communications  5  3051  2014

      Show Abstract
      24394804 24394804